Rezolute (RZLT) Retained Earnings (2011 - 2026)
Rezolute recorded quarterly Retained Earnings of -$115000.0 in Q1 2026, up 99.97% quarter-over-quarter from -$444.8 million in Q4 2025, and down 367.44% year-over-year from $43000.0 in Q1 2025.
Rezolute's Retained Earnings history runs 16 years deep, the most recent figure standing at -$115000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 367.44% year-over-year to -$115000.0; the TTM figure through Mar 2026 stood at -$115000.0 (down 367.44% YoY), while the FY2025 annual figure was -$7000.0, up 100.0% from the prior year.
- Retained Earnings came in at -$115000.0 for Q1 2026 at Rezolute, up from -$444.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $289000.0 in Q3 2024 to a low of -$444.8 million in Q4 2025.
- A 5-year average of -$174.9 million and a median of -$209.2 million in 2022 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 201.76% in 2024 and fell as far as 751050.0% in 2024.
- Rezolute's Retained Earnings stood at -$232.6 million in 2022, then soared by 99.98% to -$48000.0 in 2023, then slumped by 751050.0% to -$360.6 million in 2024, then declined by 23.36% to -$444.8 million in 2025, then jumped by 99.97% to -$115000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$115000.0, -$444.8 million, and -$422.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | -115,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115,000.00 |
| Dec 31, 2025 | -444.78 Mn |
| Sep 30, 2025 | -422.00 Mn |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | -360.55 Mn |
| Sep 30, 2024 | 289,000.00 |
| Jun 30, 2024 | -329.44 Mn |
| Mar 31, 2024 | -306.50 Mn |
| Dec 31, 2023 | -48,000.00 |
| Sep 30, 2023 | -284,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Mar 31, 2023 | -248.26 Mn |
| Dec 31, 2022 | -232.60 Mn |
| Sep 30, 2022 | -219.03 Mn |
| Jun 30, 2022 | -209.20 Mn |
| Mar 31, 2022 | -199.78 Mn |
| Dec 31, 2021 | -188.60 Mn |
| Sep 30, 2021 | -175.97 Mn |
| Jun 30, 2021 | -168.14 Mn |
| Mar 31, 2021 | -161.65 Mn |
| Dec 31, 2020 | -157.95 Mn |
| Sep 30, 2020 | -150.86 Mn |
| Jun 30, 2020 | -147.24 Mn |
| Mar 31, 2020 | -143.69 Mn |
| Dec 31, 2019 | -138.65 Mn |
| Sep 30, 2019 | -131.98 Mn |
| Jun 30, 2019 | -126.90 Mn |
| Mar 31, 2019 | -123.76 Mn |
| Dec 31, 2018 | -101.71 Mn |
| Sep 30, 2018 | -97.55 Mn |
| Jun 30, 2018 | -94.18 Mn |
| Mar 31, 2018 | -81.69 Mn |
| Dec 31, 2017 | -76.73 Mn |
| Sep 30, 2017 | -71.01 Mn |
| Jun 30, 2017 | -64.32 Mn |
| Mar 31, 2017 | -58.13 Mn |
| Dec 31, 2016 | -52.75 Mn |
| Sep 30, 2016 | -47.86 Mn |
| Jun 30, 2016 | -44.04 Mn |
| Mar 31, 2016 | -40.17 Mn |
| Dec 31, 2015 | -36.46 Mn |
| Sep 30, 2015 | -32.40 Mn |
| Jun 30, 2015 | -29.11 Mn |
| Mar 31, 2015 | -26.07 Mn |
| Dec 31, 2014 | -22.90 Mn |
| Sep 30, 2014 | 19.96 Mn |
| Jun 30, 2014 | -17.75 Mn |
| Mar 31, 2014 | 15.74 Mn |
| Dec 31, 2013 | 10.65 Mn |
| Sep 30, 2013 | 8.84 Mn |
| Jun 30, 2013 | 8.02 Mn |
| Mar 31, 2013 | 6.99 Mn |
| Dec 31, 2012 | 110,270.00 |
| Sep 30, 2012 | 100,963.00 |
| Jun 30, 2012 | 1.29 Mn |
| Mar 31, 2012 | 67,264.00 |
| Dec 31, 2011 | 890,804.00 |
| Sep 30, 2011 | 49,321.00 |
| Jun 30, 2011 | 41,927.00 |